Dihydroquercetin can inhibit RANKL-induced osteoclast differentiation and gene expression, including TRAP and MMP-9, showing potential for treating osteoporosis, bone resorption, and related diseases such as RA [34]. Here, TNFSF11 is linked to rheumatoid arthritis.